PubRank

J F Daley

Author PubWeight™ 62.20‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 B4, a human B lymphocyte-associated antigen expressed on normal, mitogen-activated, and malignant B lymphocytes. J Immunol 1983 3.09
2 Generation of monoclonal antibodies to a human natural killer clone. Characterization of two natural killer-associated antigens, NKH1A and NKH2, expressed on subsets of large granular lymphocytes. J Clin Invest 1985 2.77
3 Heterogeneity of human T4+ inducer T cells defined by a monoclonal antibody that delineates two functional subpopulations. J Immunol 1982 2.60
4 Activation of human thymocytes via the 50KD T11 sheep erythrocyte binding protein induces the expression of interleukin 2 receptors on both T3+ and T3- populations. J Immunol 1985 2.37
5 Calcium dependency of antigen-specific (T3-Ti) and alternative (T11) pathways of human T-cell activation. Proc Natl Acad Sci U S A 1984 2.17
6 Coexpression of T4 and T8 on peripheral blood T cells demonstrated by two-color fluorescence flow cytometry. J Immunol 1985 1.93
7 Ta1, a novel 105 KD human T cell activation antigen defined by a monoclonal antibody. J Immunol 1984 1.84
8 A subset of natural killer cells in peripheral blood displays a mature T cell phenotype. J Exp Med 1986 1.63
9 The T11 (CD2) molecule is functionally linked to the T3/Ti T cell receptor in the majority of T cells. J Immunol 1987 1.60
10 The T11 glycoprotein is functionally linked to a calcium channel in precursor and mature T-lineage cells. Proc Natl Acad Sci U S A 1986 1.55
11 Reconstitution after transplantation with T-lymphocyte-depleted HLA haplotype-mismatched bone marrow for severe combined immunodeficiency. Proc Natl Acad Sci U S A 1982 1.44
12 Biosynthesis and surface expression of T8 by peripheral blood T4+ cells in vitro. J Immunol 1986 1.40
13 Cell surface modulation of CD26 by anti-1F7 monoclonal antibody. Analysis of surface expression and human T cell activation. J Immunol 1990 1.35
14 Acquisition of immune competence by a subset of human cortical thymocytes expressing mature T cell antigens. J Immunol 1982 1.34
15 Clinical and immunologic effects of prolonged infusion of low-dose recombinant interleukin-2 after autologous and T-cell-depleted allogeneic bone marrow transplantation. Blood 1992 1.29
16 Reactivity of inducer cell subsets and T8-cell activation during the human autologous mixed lymphocyte reaction. Clin Immunol Immunopathol 1984 1.13
17 Expression of the CD8alpha beta-heterodimer on CD8(+) T lymphocytes in peripheral blood lymphocytes of human immunodeficiency virus- and human immunodeficiency virus+ individuals. Blood 1998 1.13
18 CD4+CD45RA+ and CD4+CD45RA- T cell subsets in man maintain distinct function and CD45RA expression persists on a subpopulation of CD45RA+ cells after activation with Con A. Cell Immunol 1990 1.12
19 CD4+CD45R+ cells are preferentially activated through the CD2 pathway. Eur J Immunol 1988 1.06
20 Smac mimetics: implications for enhancement of targeted therapies in leukemia. Leukemia 2010 1.05
21 Expression of the NKTa clonotype in a series of human natural killer clones with identical cytotoxic specificity. J Exp Med 1986 1.04
22 The 1A4 molecule (CD27) is involved in T cell activation. J Immunol 1991 1.04
23 Regulation of T cell clone function via CD4 and CD8 molecules. Anti-CD4 can mediate two distinct inhibitory activities. J Immunol 1988 1.03
24 Monocytes are required to prime peripheral blood T cells to undergo apoptosis. Proc Natl Acad Sci U S A 1995 1.03
25 The role of interleukin 2 and T11 E rosette antigen in activation and proliferation of human NK clones. J Immunol 1985 1.02
26 Molecular interaction between CD58 and CD2 counter-receptors mediates the ability of monocytes to augment T cell activation by IL-12. J Immunol 1996 1.02
27 Expression of MY7 antigen on myeloid precursor cells. Int J Cell Cloning 1983 0.98
28 Differential expression of CD8 alpha and CD8 beta associated with MHC-restricted and non-MHC-restricted cytolytic effector cells. Cell Immunol 1990 0.98
29 Regulation of CD4 and CD8 surface expression on human thymocyte subpopulations by triggering through CD2 and the CD3-T cell receptor. J Immunol 1989 0.95
30 Using combination therapy to override stromal-mediated chemoresistance in mutant FLT3-positive AML: synergism between FLT3 inhibitors, dasatinib/multi-targeted inhibitors and JAK inhibitors. Leukemia 2012 0.95
31 1F7 (CD26): a marker of thymic maturation involved in the differential regulation of the CD3 and CD2 pathways of human thymocyte activation. J Immunol 1991 0.94
32 Identification and isolation of a T4+T8+ cell with high T3 expression in human thymus: a possible late intermediate in thymocyte differentiation. J Immunol 1987 0.93
33 Class II major histocompatibility complex molecules regulate the development of the T4+T8- inducer phenotype of cultured human thymocytes. Proc Natl Acad Sci U S A 1985 0.92
34 Regions of the CD4 molecule not involved in virus binding or syncytia formation are required for HIV-1 infection of lymphocytes. J Immunol 1992 0.91
35 Growth inhibition of human T cells by antibodies recognizing the T cell antigen receptor complex. J Immunol 1987 0.91
36 Isolation and functional analysis of human B cell populations. I. Characterization of the B1+B2+ and B1+B2- subsets. J Immunol 1985 0.90
37 Isolation and characterization of CD6- T cells from peripheral blood. J Immunol 1994 0.87
38 Induction and detection of apoptosis in human periphery blood T-cells. J Immunol Methods 1997 0.85
39 Mo2: functional properties of antigen-bearing cells. Clin Immunol Immunopathol 1983 0.85
40 Expression of Ia antigens on myeloid progenitor cells in chronic myeloid leukemia: direct analysis using partially purified colony-forming cells. Blood 1985 0.85
41 Activation of immature cortical thymocytes through the T11 sheep erythrocyte binding protein. J Immunol 1987 0.84
42 Discrete stages of human thymocyte activation and maturation in vitro: correlation between phenotype and function. Eur J Immunol 1986 0.83
43 Expression of CD1 and class I MHC antigens by human thymocytes. J Immunol 1989 0.82
44 Development of natural killer cells in human thymocyte culture: regulation by accessory cells. Eur J Immunol 1987 0.81
45 Characterization of a novel subset of CD8(+) T cells that expands in patients receiving interleukin-12. J Clin Invest 1998 0.80
46 Heterogeneity in filamentous actin content among individual human blood platelets. Blood 1992 0.80
47 Quasi-simultaneous measurement of ionized calcium and alpha-granule release in individual platelets. Am J Physiol 1991 0.80
48 Signaling from LFA-1 contributes signal transduction through CD2 alternative pathway in T cell activation. Cell Immunol 1992 0.80
49 Dual fluorochrome analysis of human B lymphocytes: phenotypic examination of resting, anti-immunoglobulin stimulated, and in vivo activated B cells. J Immunol 1986 0.79
50 Human thymocyte maturation in vitro: a flow cytometric analysis. Cell Immunol 1986 0.78
51 T-cell surface antigens in a patient with blast crisis of chronic myeloid leukemia. Blood 1983 0.77
52 Cytochalasins enhance the proliferation of CD4 cells through the CD3-Ti antigen receptor complex or the CD2 molecule through an effect on early events of activation. J Immunol 1991 0.77
53 Differential regulation of Ca2+ mobilization in human thymocytes by coaggregation of surface molecules. J Immunol 1990 0.75
54 Sequential CD34+ and CD4+ cell selection from leukapheresis components. J Hematother 1998 0.75
55 Characterization of the T3+T4+T8+ thymocyte intermediate in vitro. Cell Immunol 1987 0.75
56 Human thymocyte subpopulations: maturational stages defined by the expression of the T3-T cell receptor complex. Acta Haematol 1987 0.75